Abstract
purpose. Ascorbate is required for the hydroxylation of collagen that is present in the corneal stroma. The keratan sulfate proteoglycans (KSPGs) lumican and keratocan are also present, and they interact with collagen and modulate its assembly into fibrils. In this study, ascorbate was added to a defined medium containing insulin, and its effects on the synthesis of collagen and KSPGs by keratocytes were determined.
methods. Collagenase-isolated keratocytes were cultured with or without insulin with or without ascorbate. Collagen and glycosaminoglycan synthesis was determined by collagenase digestion of incorporated 3H-glycine and by chondroitinase ABC or endo-β-galactosidase digestion of incorporated 35SO4. KSPGs were detected by Western blot. Collagen stability was determined by pepsin digestion. Ethyl-3,4-dihydroxybenzoate (EDB) was used to inhibit collagen hydroxylation.
results. Insulin stimulated the synthesis of collagen but did not affect the accumulation of lumican and keratocan. Insulin plus ascorbate, however, stimulated the synthesis of collagen and increased the accumulation of these proteoglycans. The accumulation of PGDS, a KSPG that does not interact with collagen, was not affected by ascorbate. Only the collagen synthesized in the presence of ascorbate was pepsin resistant. EDB overrode the effects of ascorbate on pepsin resistance and proteoglycan accumulation.
conclusions. The results of this study indicate that the accumulation of lumican and keratocan depends in part on the level of collagen synthesis and its hydroxylation. The interaction of lumican and keratocan with the stably folded triple helix provided by hydroxylation may also serve to stabilize these proteoglycans.
The corneal stroma contains keratocytes embedded in an extracellular matrix consisting primarily of collagen types I and V and of proteoglycans that contain either chondroitin sulfate (CS) or keratan sulfate (KS) chains. Electron microscopic studies show that the corneal stroma contains collagen fibrils of small, uniform diameter that are separated by small, uniformly sized spaces. The collagen fibrils in the corneal stroma are heterofibrils of collagen types I and V.
1 Collagen type V is essential for the initiation of fibril formation,
2 and the presence of collagen V in the heterofibril has been shown to limit the fibril diameter growth.
3 The proteoglycans are in the spaces between the fibrils in vivo,
4 and in vitro assays that measure collagen fibril assembly have shown that these proteoglycans modulate collagen fibril formation.
5 6 7 Collagen fibril formation in the presence of CS and KS proteoglycans purified from the cornea delay fibril formation, decrease the rate of fibril growth, and result in smaller collagen fibrils.
8 The removal of the GAG side chains did not affect the activity of the proteoglycans, but reduction and alkylation abolished the activity. This indicates that the core protein of these proteoglycans modulates collagen assembly into fibrils.
8 9 The major proteoglycans of the corneal stroma are decorin,
10 lumican,
11 12 and keratocan.
13 Decorin is a CS proteoglycan, whereas keratocan and lumican are KS proteoglycans. Keratocan-null
14 15 and lumican-null
16 17 18 mice have thinner corneas, and the collagen fibrils in the stromas are larger and less organized than in the stromas of normal mice, confirming the in vitro turbidimetry analysis of collagen fibril assembly. Taken together, these findings indicate that collagen type I assembly into fibrils is modulated by both collagen type V and the keratan sulfate proteoglycans in the stroma.
Three procollagen polypeptides come together to form a left-handed triple helix immediately after synthesis.
19 20 Stable triple helix formation, however, can occur only if certain lysine and proline residues in the collagen molecule are hydroxylated.
21 This posttranslational hydroxylation is performed by either lysyl or prolyl hydroxylases.
22 These enzymes are found in the lumen of the endoplasmic reticulum (ER)
20 and require ascorbic acid as a cofactor.
23 Ascorbate deficiency in cell culture does not affect collagen synthesis but affects fibril formation and the rate of collagen secretion.
24 25 26 The nonhydroxylated collagen molecules denature at a lower temperature and in less stringent environments than properly hydroxylated collagen fibrils.
27 Systemic ascorbate deficiency leads to scurvy, and this deficiency affects wound healing. Scorbutic wounds are weaker
28 than nonscorbutic wounds, are prone to reopen, and contain a mass of irregular, unorganized collagen fibrils.
29
The cornea and anterior segment of the eye contain high levels of ascorbate,
30 and it is thought to function as an antioxidant and protect the cornea from reactive oxygen species that result from UV irradiation.
31 32 The levels of ascorbate in the aqueous humor and the cornea decrease after an alkali burn,
33 resulting in the cornea’s becoming scorbutic. The cells in the stroma show characteristics of scorbutic tissue such as a sparse ER, suggesting that they are not very metabolically active.
34 Topical ascorbate has been used successfully to treat corneal alkali burns and has been proposed to do so by increasing the synthesis and secretion of properly folded collagen to replace the collagen denatured by the burn.
35 In addition, topical ascorbate has been used after photorefractive keratectomy (PRK), and its use decreased the late onset of corneal haze.
36 Ascorbate concentration is highest in the epithelium, the layer that is removed before PRK. Although the exact reason for the late onset corneal haze is not known, it is possible that removal of part of the epithelium before PRK results in a decrease in ascorbate levels in the anterior corneal stroma, and we further speculate that this decline may reduce the secretion of properly folded collagen, which could result in corneal haze.
Ascorbic acid has been used to study collagen synthesis in culture,
22 but it is easily oxidized in solution and its metabolic by-products are cytotoxic in extended cell culture.
37 A stable, nontoxic phosphate derivative of ascorbic acid (2-phospho-L-ascorbic acid) was developed
38 and has been shown to stimulate collagen accumulation by skin fibroblasts in culture and also to enhance the secretion of type I and III collagen peptides by rabbit keratocytes cultured in medium containing fetal bovine serum.
39 Serum, however, contains mitogens and morphogens that cause keratocytes in culture to proliferate, acquire a fibroblastic morphology, and cease keratocan expression.
40 41 42 A chemically defined medium containing insulin has been shown to stimulate keratocyte proliferation while maintaining the dendritic morphology as well as keratocan expression.
43 In this study, keratocytes were cultured in this defined medium containing 2-phospho-
l-ascorbic acid, to determine its effects on the synthesis and accumulation of collagen and KS proteoglycans.
Cell layers were harvested on days 1, 4, 7, and 10, to measure DNA content (Cyquant; Invitrogen). Briefly, the cell layers were rinsed with PBS, frozen, thawed, and solubilized in a lysis buffer supplemented with a DNA-binding dye. The DNA content was determined at 480/535 nm by measuring four wells in triplicate and comparing the values to a calf thymus DNA standard. The DNA content of parallel cultures was measured for experiments that used the cell layer.
Medium from cells was adjusted to 0.5 M acetic acid and concentrated eightfold (Amicon Ultra spin concentrators, MWCO [molecular weight cutoff] 10,000; Millipore Corp., Bedford, MA). Fifty microliters of a 4-mg/mL pepsin solution (in 0.5 M acetic acid) per 3 mL was added, and the samples were rocked overnight at 4°C. Each sample received a second 50-μL aliquot from the pepsin stock, and digestion was allowed to continue for an additional 6 hours at 4°C. The samples were titrated with 1 N NaOH to pH 8.0, to inactivate the enzyme, dialyzed against water overnight, lyophilized, reconstituted in 1× SDS running buffer, and separated on 10% bis-tris gels in reducing conditions. The gels were stained according to the manufacturer’s protocol (SimplyBlue Safestain; Invitrogen).